Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hillerød – page 56

1 196 clinical trials in Hillerød, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hillerød at a glance
1 196
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 196 trials in Hillerød

Open in trial search

Hypertriglyceridaemia

Not recruiting

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Astegolimab
  • Sponsor:F. Hoffmann-La Roche AG

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Arthralgia

Not recruiting

Study on the Effects and Safety of ODM-111 and Paracetamol for Chronic Knee Pain in Osteoarthritis Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ODM-111
  • Sponsor:Orion Corporation

Trigeminal neuralgia

Not recruiting

Study on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Basimglurant
  • Sponsor:Noema Pharma AG

Crohn's disease

Not recruiting

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Safety and Effects of NPI-001 (Acetylcysteine Amide) for Patients Aged 50-85 with Mild Cognitive Impairment or Mild Alzheimer's Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
  • Sponsor:Arctic Therapeutics hf.

Neoplasm

Not recruiting

Study of Trastuzumab Deruxtecan Treatment for Patients with Advanced Solid Tumors Having HER2 Mutations

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:AstraZeneca AB

Schizophrenia

Not recruiting

Study on Semaglutide for Preventing Metabolic Issues in Prediabetic or Diabetic Patients with Schizophrenia on Clozapine or Olanzapine

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Semaglutide
  • Sponsor:Psykiatrisk Center Kobenhavn

Hodgkin's disease

Not recruiting

Study Comparing Brentuximab Vedotin with Drug Combination for Treating Advanced Classical Hodgkin Lymphoma in Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin
  • Sponsor:Takeda Development Center Americas Inc.

B-cell lymphoma+1

Not recruiting

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Genmab A/S

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hillerød

What the registry says about research in the country

01 Gastroenterology Research

Ongoing clinical trials focusing on inflammatory bowel diseases, particularly investigating new treatments for Crohn's Disease and Ulcerative Colitis. Studies are evaluating the effectiveness of oral medications and biological therapies for managing moderate to severe cases.

  • Treatment optimization studies
  • Long-term disease management
  • Bowel wall healing assessment

Advanced therapeutic approaches aim to improve patient outcomes and quality of life.

02 Metabolic Disorders

Research initiatives targeting obesity and type 2 diabetes, with trials exploring innovative treatments combining medication with lifestyle modifications. Special focus on investigating new therapies for patients with concurrent weight management needs.

  • Weight management protocols
  • Diabetes control strategies
  • Combined therapeutic approaches

Studies aim to improve metabolic health outcomes through targeted interventions.

03 Cardiovascular Studies

Innovative research focusing on heart failure prevention and management of atrial fibrillation. Clinical trials are evaluating new medications and therapeutic combinations to reduce cardiovascular risks and improve patient outcomes.

  • Preventive cardiology
  • Stroke prevention
  • Cardiac treatment optimization

Advanced approaches in cardiovascular disease management and prevention.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.